GT Biopharma (GTBP) Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules May 21, 2024 09:15AM
GT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules May 21, 2024 09:15AM
Roth Capital Downgrades GT Biopharma Inc. (GTBP) to Neutral Aug 11, 2022 03:31PM
UPDATE: Roth Capital Starts GT Biopharma Inc. (GTBP) at Buy Mar 17, 2021 05:05AM
GT Biopharma Announces Closing of $23.7 Million Public Offering Feb 16, 2021 08:00AM


Feb 11, 2021 08:00AM GT Biopharma Announces Pricing of $23,650,000 Public Offering and Uplisting to The Nasdaq Capital Market
Mar 13, 2018 07:30AM GT Biopharma to Present at Roth Capital Partners 30th Annual Conference
Jan 23, 2018 09:10AM GT Biopharma Announces $7.1 Million Convertible Debt Financing
Jan 23, 2018 09:00AM GT Biopharma Announces $7.1 Million Convertible Debt Financing
Jan 23, 2018 09:00AM GT Biopharma Announces $7.1 Million Convertible Debt Financing